Valion Bio, Inc. (VBIO) stock
VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.53+0.02 (+4.05%)
Close on Nov 13, 2026Market cap $2.20MP/E –Yield –
Valion Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Valion Bio's price to sales ratio was 102.6× on Jan 30, 2026, against 38.4× a year earlier. Over the last 4 years it ranged from 6.6× to 401.3×, with a median of 64.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 102.6× | −22.4 |
| 2025 | Dec 31, 2025 | 125.1× | +68.6 |
| 2024 | Dec 31, 2024 | 56.5× | +2.7 |
| 2023 | Dec 29, 2023 | 53.8× | −31.2 |
| 2022 | Dec 30, 2022 | 85.0× | – |
See a number that looks wrong?